Innate immune cells and synovial immune milieu

The innate immune cells and synovial immune milieu represent the integrated biological system of the joint lining, comprising various cell types and the extracellular signaling environment. Key cellular components include synovial macrophages, neutrophils, and natural killer cells, which interact with resident fibroblast-like synoviocytes to regulate joint homeostasis [1]. In inflammatory arthropathies such as rheumatoid arthritis, this milieu undergoes a profound shift toward a pro-inflammatory state, characterized by the infiltration of leukocytes and the high-level secretion of cytokines like Tumor Necrosis Factor (TNF) and Interleukin-6 (IL-6) [2]. This environment is not a single druggable protein but rather a complex pathological niche where multiple therapeutic agents, including monoclonal antibodies and JAK inhibitors, act to disrupt inflammatory cascades [3]. Targeting the components of this milieu is essential for reducing synovial hyperplasia, preventing cartilage degradation, and mitigating bone erosion in patients with autoimmune joint diseases [4]. Therapeutic strategies often focus on depleting specific cell populations or neutralizing the soluble factors that define this milieu to restore immune tolerance. Understanding the heterogeneity of the synovial milieu is increasingly important for the development of personalized treatment strategies in rheumatology. References: [1] Firestein GS, McInnes IB. Immunity. 2017;46(2):183-196. [2] Weyand CM, Goronzy JJ. Nat Immunol. 2021;22(1):10-18. [3] McInnes IB, Schett G. N Engl J Med. 2011;365(23):2205-2219. [4] Rivellese F, et al. Nat Rev Rheumatol. 2022;18(6):335-349.

Other names

Synovial microenvironmentJoint immune milieuSynovial inflammatory environmentSynovial immune landscape

Modulation of the synovial inflammatory environment through the inhibition of pro-inflammatory cytokines, depletion of specific immune cell subsets, or blockade of intracellular signaling pathways.